-
1 Comment
Walvax Biotechnology Co., Ltd is currently in a long term uptrend where the price is trading 22.7% above its 200 day moving average.
From a valuation standpoint, the stock is 152.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 24.3.
Walvax Biotechnology Co., Ltd's total revenue rose by 323.9% to $1B since the same quarter in the previous year.
Its net income has increased by 2527.6% to $568M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.2% to $-137M since the same quarter in the previous year.
Based on the above factors, Walvax Biotechnology Co., Ltd gets an overall score of 3/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE100000WN2 |
| Exchange | SHE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 1232.0 |
|---|---|
| Target Price | 8 |
| Dividend Yield | 0.1% |
| Market Cap | 20B |
| Beta | 0.39 |
Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300142.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
